A Multimodal Intervention to Optimise Antimicrobial Use in Residential Aged Care Facilities (ENGAGEMENT Study)

NCT ID: NCT04705259

Last Updated: 2021-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-01

Study Completion Date

2022-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The antimicrobial stewardship ENGAGEMENT study aims to deliver a bundle of interventions, including education of GPs and nursing staff, guideline implementation and telehealth support for 18 residential aged care facilities (RACFs) in Queensland Australia to help optimise antibiotic prescribing and reduce inappropriate use. The trial will involve 18 licenced RACFs with 50 or more residents and is set to commence in June 2021.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INTRODUCTION Inappropriate antibiotic use can cause harm and promote antimicrobial resistance, which has been declared a major health challenge by the World Health Organisation. In Australian Residential Aged Care Facilities (RACFs), the most common indications for antibiotic prescribing are for suspected infections of the urinary tract, respiratory tract, and skin and soft tissue. Studies indicate that a high proportion of these prescriptions are noncompliant with best prescribing guidelines. To date a variety of interventions have been reported to address inappropriate prescribing and overuse of antibiotics but with mixed outcomes. The present study aims to identify the impact of a set of sustainable, multi-modal interventions in residential aged care targeting three common infection types, using a robust methodology.

METHODS AND ANALYSIS This study will be conducted using a stepped-wedge cluster randomised trial that will recruit 18 RACFs (each RACF will be considered as one cluster), over a 20 month observation period. Initially an antimicrobial stewardship needs assessment toolkit will be piloted in seven RACFs from different service providers. This will enable the refinement and targeted implementation of the intervention bundle, based on existing requirement of facilities. A multimodal multi-disciplinary set of interventions, the 'ENGAGEMENT bundle', will be tailored to the needs of facilities. This bundle will be implemented as part of the stepped wedge randomised control trial. The key elements of the intervention bundle include education for nurses and general practitioners, telehealth support and formation of an antimicrobial stewardship team. Prior to the sequential introduction of the intervention, each site will act as its own control, in relation to usual care processes for antibiotic use and stewardship.

The primary outcome for this study will be antibiotic consumption measured using defined daily doses (DDDs). Cluster-level rates will be calculated using total occupied bed numbers within each RACF during the post-randomisation observation period as the denominator. Results will be expressed as rates per 1000 occupied bed days. An economic analysis will be conducted to compare the costs associated with the intervention to that of usual care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antimicrobial Stewardship Antibiotics Causing Adverse Effects in Therapeutic Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Stepped wedge randomised control study
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Education intervention where the facilities will be made aware of best practice guidelines and protocols with respect to antibiotic prescribing

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ENGAGEMENT bundle

A multimodal bundle of interventions to optimise antibiotic prescribing in residential aged care facilities. The bundle includes education for nurses and general practitioners caring for residents, telehealth support and implementation of state-wide guidelines.

Group Type ACTIVE_COMPARATOR

Antimicrobial Stewardship ENGAGEMENT bundle

Intervention Type BEHAVIORAL

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs \[7\], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:

* Education and engagement of prescribers, nurses, pharmacists and residents and family members
* Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing
* Guideline development specific to antibiotic use in RACF residents
* Antimicrobial stewardship team creation in RACF with GP involvement
* EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum
* ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing
* Telehealth support for key intervention components

Usual care

Usual facility practices with regards to antibiotic prescribing and review

Group Type PLACEBO_COMPARATOR

Antimicrobial Stewardship ENGAGEMENT bundle

Intervention Type BEHAVIORAL

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs \[7\], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:

* Education and engagement of prescribers, nurses, pharmacists and residents and family members
* Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing
* Guideline development specific to antibiotic use in RACF residents
* Antimicrobial stewardship team creation in RACF with GP involvement
* EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum
* ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing
* Telehealth support for key intervention components

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Antimicrobial Stewardship ENGAGEMENT bundle

Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs \[7\], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:

* Education and engagement of prescribers, nurses, pharmacists and residents and family members
* Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing
* Guideline development specific to antibiotic use in RACF residents
* Antimicrobial stewardship team creation in RACF with GP involvement
* EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum
* ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing
* Telehealth support for key intervention components

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All residents of RACFs with at least 50 residents
* RACFs located in South East Queensland, Australia

Exclusion Criteria

* RACFs with less than 50 residents;
* RACFs unable to provide reports for baseline data
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Health and Medical Research Council, Australia

OTHER

Sponsor Role collaborator

The University of Queensland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bethany Christian Care

Eight Mile Plains, Queensland, Australia

Site Status RECRUITING

Carinity Aged Care

Mitchelton, Queensland, Australia

Site Status RECRUITING

Beaumont Care

Rothwell, Queensland, Australia

Site Status RECRUITING

Vacenti Aged Care

Upper Mount Gravatt, Queensland, Australia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Australia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alyssa Welch

Role: CONTACT

+61438629310

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sue Weller

Role: primary

+61737375000

Tunde Bulman

Role: primary

+61735503745

Krystell Harward

Role: primary

+61732033633

Hannah Carroll

Role: primary

+61734229300

References

Explore related publications, articles, or registry entries linked to this study.

Falconer N, Paterson DL, Peel N, Welch A, Freeman C, Burkett E, Hubbard R, Comans T, Hanjani LS, Pascoe E, Hawley C, Gray L. A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial. Trials. 2022 May 21;23(1):427. doi: 10.1186/s13063-022-06323-8.

Reference Type DERIVED
PMID: 35597993 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020002193

Identifier Type: -

Identifier Source: org_study_id